About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
L
IDWeek 2023 Highlights for HIV Clinicians
By
UCSF School of Medicine
FEATURING
Lisa Winston
,
Ayesha Appa
By
UCSF School of Medicine
FEATURING
Lisa Winston
,
Ayesha Appa
93 views
March 1, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
30:30
UCSF School of Medicine
HIV on the Brain: Cases in Neurology & HIV - Differential Diagno…
Feat.
F. Chow
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
14:47
Johns Hopkins Infectious Disease
Basics of Licensed Vaccine Design and Impact
Feat.
A. Durbin
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
22:46
Ina Park
CDC Laboratory Guidelines for the Diagnosis of Syphilis
20:24
Diana Isaacs
Tirzepatide for Type 2 Diabetes
26:49
Diana Isaacs
Tirzepatide Updates
24:44
Diego Hijano
What Physicians Need to Know About Influenza, COVID-19, and RSV?
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
60:26
Scripps Health
What's New in Infectious Diseases
Feat.
N. Crum-Cianflone
36:34
Scripps Health
GLP-1 Hysteria
Feat.
S. Harris
13:33
Dr. Sharmila Ghimire
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesi…
Feat.
D. Ghimire
13:09
MedCram
Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…
Feat.
R. Seheult
27:07
MicrobeTV
Vaccine Effectiveness in Children and Adolescents, How Vaccination M…
Feat.
D. Griffin,
V. Racaniello
05:40
Susan Brian
An Introduction to Tirzepatide for Weightloss
